CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid Hemangioendothelioma
Dinaciclib 抑制 CDK9 是上皮样血管内皮瘤的治疗弱点
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-24-1097
Ajaybabu V Pobbati, Ashley Burtscher, Nandini Rajaram Siva, Andrea Hallett, Todd Romigh, Kepeng Che, Bin Zhao, Jesse A Coker, Nancy Wang, Shaun R Stauffer, Brian P Rubin